Profile
IXP, an acronym for Innovation Acceleration Platform, acts as a growth engine for Lifesciences startups to seed and scale innovative ideas. The platform is built on the premise that the rate-limiting step for a scientist on an entrepreneurial journey is not funding alone, but also availability of laboratory space, access to networks of seasoned entrepreneurs/partners in the industry and curated services for externalization of R&D. We catalyse scaling of early-stage companies through access to seed-/growth- capital, ready-to-move labs and strong industry connects. The key differentiator for the platform is the well-networked team with diverse expertise at the intersection of private equity and Lifesciences R&D.
Industry
Region of investment
IXP Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
IXP Lifesciences Catalyst Fund
|
Venture Capital (VC)
|
Medical Devices
MedTech
Life Sciences
HealthTech
|
Pre-seed
Seed
Series A
|
Asia
|
$5-10 m
|
$23 M
|
February 2025
|